The Meaning of VOR - Vortainment
Vor Therapeutics has partnered with Abound Bio to develop a clinical trial for its engineered hematopoietic stem cell product candidate, VOR33, targeting acute myeloid leukemia. The company, led by Dr. Siddhartha Mukherjee, expects to enroll the first patient in the second quarter of 2021. The VOR team also provides cyber intelligence and security solutions.
Vortainment
- Entities
- CAR-T Therapy
- Security Solutions
- Siddhartha Mukherjee
- Cyber Intelligence
- Vor Therapeutics
- Abound Bio
- VOR33
- Hematopoietic Stem Cell Therapy
Original source
This article was reported and published by Vortainment. feed.gg links to it as part of a story cluster — full text, images and rights remain with the publisher.